Evidence map›Paper›PMID 30887098›Full record

ArticleCellular and molecular life sciences : CMLS2019

A critical role for miR-142 in alveolar epithelial lineage formation in mouse lung development.

Amit Shrestha, Gianni Carraro, Nicolas Nottet, Ana Ivonne Vazquez-Armendariz, Susanne Herold, Julio Cordero, Indrabahadur Singh, Jochen Wilhelm, Guillermo Barreto, Rory Morty and 6 more

Open access · greenAbstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Genome-wide integration of microRNA and transcriptomic profiles of differentiating human alveolar epithelial cells.American journal of physiology. Lung cellular and molecular physiology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 5 countries.

Amit ShresthaDepartment of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Gianni CarraroDepartment of Medicine, Cedars-Sinai Medical Center, Lung and Regenerative Medicine Institutes, Los Angeles, CA, USA.
Nicolas NottetCentre National de la Recherche Scientifique, CNRS, UMR 7275, Institut de Pharmacologie Moleculaire et Cellulaire (IPMC), Sophia Antipolis, France.
Ana Ivonne Vazquez-ArmendarizCardio-Pulmonary Institute (CPI), Member of the German Center for Lung Research (DZL), Universities of Giessen and Marburg Lung Center (UGMLC), Justus-Liebig-University Giessen, 35392, Giessen, Germany.
Susanne HeroldCardio-Pulmonary Institute (CPI), Member of the German Center for Lung Research (DZL), Universities of Giessen and Marburg Lung Center (UGMLC), Justus-Liebig-University Giessen, 35392, Giessen, Germany.
Julio CorderoLung Cancer Epigenetics, Member of the German Center of Lung Research (Deutsches Zentrum für Lungenforschung, DZL), Max-Planck-Institute for Heart and Lung Research, 61231, Bad Nauheim, Germany.
Indrabahadur SinghLung Cancer Epigenetics, Member of the German Center of Lung Research (Deutsches Zentrum für Lungenforschung, DZL), Max-Planck-Institute for Heart and Lung Research, 61231, Bad Nauheim, Germany.
Jochen WilhelmCardio-Pulmonary Institute (CPI), Member of the German Center for Lung Research (DZL), Universities of Giessen and Marburg Lung Center (UGMLC), Justus-Liebig-University Giessen, 35392, Giessen, Germany.
Guillermo BarretoLung Cancer Epigenetics, Member of the German Center of Lung Research (Deutsches Zentrum für Lungenforschung, DZL), Max-Planck-Institute for Heart and Lung Research, 61231, Bad Nauheim, Germany.
Rory MortyDepartment of Lung Development and Remodeling, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany.
Elie El AghaDepartment of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Bernard MariCentre National de la Recherche Scientifique, CNRS, UMR 7275, Institut de Pharmacologie Moleculaire et Cellulaire (IPMC), Sophia Antipolis, France.
Chengshui ChenDepartment of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Jin-San ZhangDepartment of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Cho-Ming ChaoDepartment of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China. Cho-Ming.Chao@paediat.med.uni-giessen.de.
Saverio BellusciDepartment of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China. saverio.bellusci@innere.med.uni-giessen.de.ORCID http://orcid.org/0000-0001-5987-4579
Justus-Liebig-Universität Gießen · DEMax Planck Institute for Heart and Lung Research · DECentre National de la Recherche Scientifique · FRCedars-Sinai Medical Center · USKazan Federal University · RUWenzhou Medical University · CNWenzhou University · CN

Funding

Deutsche Forschungsgemeinschaft BE4443/1-1Deutsche Forschungsgemeinschaft BE4443/4-1
6 · The paper itself

Abstract

The respiratory epithelium arises from alveolar epithelial progenitors which differentiate into alveolar epithelial type 1 (AT1) and type 2 (AT2) cells. AT2 cells are stem cells in the lung critical for the repair process after injury. Mechanisms regulating AT1 and AT2 cell maturation are poorly defined. We report that the activation of the glucocorticoid pathway in an in vitro alveolar epithelial lineage differentiation assay led to increased AT2 marker Sftpc and decreased miR-142 expression. Using miR-142 KO mice, we demonstrate an increase in the AT2/AT1 cell number ratio. Overexpression of miR-142 in alveolar progenitor cells in vivo led to the opposite effect. Examination of the KO lungs at E18.5 revealed enhanced expression of miR-142 targets Apc, Ep300 and Kras associated with increased β-catenin and p-Erk signaling. Silencing of miR-142 expression in lung explants grown in vitro triggers enhanced Sftpc expression as well as increased AT2/AT1 cell number ratio. Pharmacological inhibition of Ep300-β-catenin but not Erk in vitro prevented the increase in Sftpc expression triggered by loss of miR-142. These results suggest that the glucocorticoid-miR-142-Ep300-β-catenin signaling axis controls pneumocyte maturation.

Indexed as

Cell LineageOrganogenesisAlveolar Epithelial CellsAnimalsCells, CulturedLungMiceMice, KnockoutMicroRNAsRespiratory MucosaMicroRNAsMirn142 microRNA, mouseAlveolar epitheliumBeta-cateninEP300LungmicroRNA-142

Identifiers

PMID30887098
PMCPMC11105218
OpenAlexW2920894883

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.